证券记录 · 已归档季度
DAWN
Day One Biopharmaceuticals, Inc. · Healthcare · Biotechnology
14被追踪持有人
0Δ持有人
10.71M持有股份
$135.72M报告持仓市值
+1新建仓位
−1清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 -16.8% · 净新建仓位 0.0% — 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q4 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q1 2026 | 86 | +1 | 49.82M | $1.05B | +13 | −13 |
| Q4 2025 | 86 | +2 | 51.33M | $478.37M | +3 | — |
| Q3 2025 | 15 | -1 | 35.84M | $252.66M | — | −2 |
| Q2 2025 | 14 | -1 | 36.93M | $240.03M | +1 | −2 |
| Q1 2025 | 12 | -2 | 10.53M | $83.51M | — | −2 |
| Q4 2024 | 14 | 0 | 10.71M | $135.72M | +1 | −1 |
| Q3 2024 | 13 | -1 | 9.77M | $136.05M | +1 | −2 |
| Q2 2024 | 14 | — | 8.62M | $118.84M | — | — |
持有人 · Q4 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (被动) | 3.10M | — | $39.30M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 1.71M | -33.0% | $21.62M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 1.71M | -33.0% | $21.62M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (被动) | 1.46M | +2.1% | $18.54M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (被动) | 1.46M | +2.1% | $18.54M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Marshall Wace ✦ | 1.10M | 新增 | $13.91M | 0.0% | New | 1 | SEC ↗ |
| 7 | Marshall Wace ✦ | 1.10M | 新增 | $13.91M | 0.0% | New | 1 | SEC ↗ |
| 8 | Adage Capital Partners ✦ | 800.00K | -11.1% | $10.14M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | Wellington Management ✦ | 731.30K | +1.4% | $9.27M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | Wellington Management ✦ | 731.30K | +1.4% | $9.27M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | Wellington Management ✦ | 731.30K | +1.4% | $9.27M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 611.31K | +26.2% | $7.75M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 611.31K | +26.2% | $7.75M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | Two Sigma Investments ✦ | 271.78K | -33.3% | $3.44M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | Renaissance Technologies ✦ | 243.74K | +157.0% | $3.09M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | Millennium Management ✦ | 192.10K | +80.4% | $2.43M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | Norges Bank ✦ (被动) | 169.00K | 0.0% | $2.14M | 0.0% | Held | 3 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 146.38K | +2.3% | $1.85M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 19 | D. E. Shaw & Co. ✦ | 146.38K | +2.3% | $1.85M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 20 | Fisher Asset Management ✦ | 89.13K | +21.6% | $1.13M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 88.20K | -32.3% | $1.12M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 88.20K | -32.3% | $1.12M | 0.0% | ▼ Trim | 3 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Marshall Wace | $13.91M | 0.0% |
| Marshall Wace | $13.91M | 0.0% |
已清仓
| Viking Global Investors | $35.64M | 曾为 0.1% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 206 持有人, 83.68M 股份, $1.67B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q4 2024 ·
方法论 ·
通过API获取此数据